In the Media

Cannabis Investment: Canadian Cannabis Stocks
A legalization movement around the globe has propelled cannabis investment to enter the headspace of investors as a legitimate play for an emerging market seeking...
Source: Investing News Network
InMed Pharmaceuticals and UBC Receive Grant From NSERC
InMed Pharmaceuticals Inc., announces that their research partner, the University of British Columbia (UBC), has been approved to receive a grant from the Natural Sciences and Engineering...
Source: Laboratory Focus
InMed Files Patent Application for its Cannabinoid Biosynthesis Program
InMed Pharmaceuticals Inc. (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary biosynthesis platform technology to develop novel therapeutics for the treatment of...
Source: City Biz List
Are cannabinoids the new wave for treating human diseases?
While many of the stigmas and steadfast opinions against marijuana use have begun to dissolve, the U.S. government still currently classifies marijuana as a Schedule 1...
Source: Healthcare Global
CBD Research Makes Headway with New Medical Treatments
CBD Researchers Make Strides Medical and Biotech research firms are getting a lot closer to bringing Cannabinoid, or CBD remedies into the main stream. Further,...
Source: Phil Hulett and Friends Podcast